Washington, DC (January 28, 2013)—
The Personalized Medicine Coalition (PMC) today submitted comments to the Center for Medicare & Medicaid Services (CMS) in response to its Draft Guidance for the Public, Industry, and CMS Staff - Coverage with Evidence Development (“CED”) in the Context of Coverage Decisions.
PMC urged CMS to consider the following recommendations:
Edward Abrahams, president of PMC, stated, "We will have continued support for CED provided that the new policy does not negatively affect the ability of clinicians to provide the optimal treatment to each patient based on the patient's individualized needs."
PMC's full comment letter may be accessed here.
About the Personalized Medicine Coalition:
The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. For more information about PMC, visit www.personalizedmedicinecoalition.org.